| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |